噬血现象、白介素-18与I型干扰素的多重交互区分Still病与其他自身炎症性疾病
该研究通过血浆蛋白质组学与免疫细胞转录组学分析372例系统性自身炎症性疾病(SAID)患者,比较Still病(SD,n=72)与非SD的SAID(n=300)。发现血浆血红素加氧酶1(HO-1)与白介素-18(IL-18)升高且强相关,是SD的特征但不关联一般炎症;SD还表现为血浆铁死亡、单核细胞转录组I型干扰素信号及自然杀伤细胞miRNA-146a-5p升高。特征模块可区分SD与其他SAID,并据噬血细胞活性将SD分为两个亚组。
要点
- 血浆HO-1与IL-18升高且强相关可特征性区分Still病,但不反映一般炎症。
- Still病伴随血浆铁死亡、单核细胞I型干扰素信号及NK细胞miRNA-146a-5p升高。
- 基于噬血细胞活性可将Still病患者分为两个亚组,与疾病活动度或炎症无关。
核心结论
- 噬血现象、IL-18与I型干扰素信号的复杂交互作用是Still病的特征。
- Still病患者可根据噬血细胞活性程度分为两个不同亚组。
研究设计与样本
- 使用SomaScan检测血浆蛋白质组,RNA测序分析免疫细胞miRNA与RNA转录组,共纳入372例SAID患者,其中SD 72例、非SD SAID 300例。
- 蛋白质组学发现通过酶联免疫吸附试验验证,并采用加权基因共表达网络分析进行整合无偏分析。
主要发现
- 血浆HO-1与IL-18升高且强相关,是SD的特征,但不与一般炎症相关。
- SD特征包括血浆铁死亡、单核细胞转录组I型干扰素信号以及自然杀伤细胞miRNA-146a-5p升高,后者为IL-18诱导的miRNA。
- 识别出可区分SD与其他SAID的特征模块,并将SD患者分为两个亚组,与疾病活动度或炎症无关,而与噬血细胞活性有关。
临床怎么用
- 血浆HO-1与IL-18联合检测有助于从其他SAID中识别Still病。
- 评估噬血细胞活性可用于Still病患者的亚组分层。
- 单核细胞I型干扰素信号与NK细胞miRNA-146a-5p可作为Still病的辅助特征标志。
局限性
- 研究为观察性组学分析,未报告诊断阈值或前瞻性验证。
- SD亚组分层未在独立队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult-onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory diseases (SAID). METHODS: Using the SomaScan assay and RNA sequencing (RNA-Seq), we determined the plasma proteomes and immune cell microRNA (miRNA) and RNA transcriptomes of 372 patients with SAID, respectively. Proteomic findings were validated by enzyme-linked immunosorbent assays. SD (n = 72) and non-SD SAIDs (n = 300) were compared to identify distinguishing features of SD. We performed integrated and unbiased analyses of all data sets using weighted gene correlation network analysis to identify feature modules that characterize SD and stratify patients. RESULTS: Elevated plasma heme oxygenase 1 (HO-1) and interleukin-18 (IL-18) strongly correlate and characterize SD but do not associate with general inflammation. SD was characterized by ferroptosis in plasma, type I interferon (IFN) signaling in monocyte transcriptomes, and elevated natural killer cell miRNA-146a-5p, which is an IL-18 induced miRNA. Finally, we identified feature modules that distinguish SD from other SAIDs and stratified patients with SD into two distinct subgroups not attributable to disease activity or inflammation but hemophagocytosis. CONCLUSION: This unprecedented large omics data set of SAIDs revealed that complex interactions among hemophagocytosis, IL-18, and type I IFN signaling characterize SD. Furthermore, two distinct subgroups in patients with SD were distinguished by the degree of hemophagocytic activity. Finally, the large proteomics and RNA-Seq data sets generated in this study can serve as an invaluable resource for the further investigation of SD and other SAIDs.
引用
- Mueller YM, Girard C, van de Werken HJG, et al. A Multifaceted Interplay Among Hemophagocytosis, Interleukin-18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases. Arthritis Rheumatol. 2026. PMID: 41728940. doi:10.1002/art.70102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。